Moderna to report Q3 amid valuation debate, cancer vaccine results: What to expect

Moderna Q3 earnings preview: vaccine sales, cash burn, and cancer vaccine trial results are in focus.

CryptoAlerta — análise de criptomoedas e mercado em tempo real